Photo from Stephen Liu/X
Jul 3, 2024, 02:46
Malak Alharbi: Stephen V. Liu discusses treatment algorithm for early-stage NSCLC
Malak Alharbi, Hematology/Oncology Fellow at Roswell Park, made the following post on X:
“Dr. Stephen V. Liu discussed treatment algorithm for early-stage NSCLC.
1. Is pCR a surrogate marker for better overall survival in lung cancer??
2. Most important steps; determining respectability & testing for driving mutations.”
Source: Malak Alharbi/X
